Non Alcoholic Fatty Liver Disease is considered to cover a spectrum of disease activity. A liver can remain fatty without disturbing liver function, but by varying mechanisms and possible insults to the liver may also progress to become non-alcoholic steatohepatitis (NASH), a state in which steatosis is combined with inflammation and fibrosis. The median patient age was 53 years, and 77% of the individuals were women. Most (67.7%) participants were obese, and a large waist circumference was observed in 80.2% subjects. Almost 70% of the participants had metabolic syndrome, and 62.3% presented evidence of either insulin resistance or overt diabetes. Most patients (51.5, 58.5, and 61.7%, respectively) exceeded the recommendations for energy intake, as well as total and saturated fat.
Tests and procedures used to diagnose nonalcoholic fatty liver disease include:Blood tests and Imaging procedures-Imaging procedures used to diagnose fatty liver disease include ultrasound, computerized tomography (CT) scan and magnetic resonance imaging (MRI), Liver tissue testing
A wide range of diseases and conditions can increase your risk of nonalcoholic fatty liver disease, including: Obesity, Polycystic ovary syndrome, Sleep apnea, Type 2 diabetes, Underactive thyroid (hypothyroidism)